BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10330143)

  • 1. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
    Yang SH; Galanis A; Sharrocks AD
    Mol Cell Biol; 1999 Jun; 19(6):4028-38. PubMed ID: 10330143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational control of the MEF2A transcriptional regulatory protein.
    Ornatsky OI; Cox DM; Tangirala P; Andreucci JJ; Quinn ZA; Wrana JL; Prywes R; Yu YT; McDermott JC
    Nucleic Acids Res; 1999 Jul; 27(13):2646-54. PubMed ID: 10373581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
    Marinissen MJ; Chiariello M; Pallante M; Gutkind JS
    Mol Cell Biol; 1999 Jun; 19(6):4289-301. PubMed ID: 10330170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.
    Yang SH; Whitmarsh AJ; Davis RJ; Sharrocks AD
    EMBO J; 1998 Mar; 17(6):1740-9. PubMed ID: 9501095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.
    Han J; Jiang Y; Li Z; Kravchenko VV; Ulevitch RJ
    Nature; 1997 Mar; 386(6622):296-9. PubMed ID: 9069290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity determinants in MAPK signaling to transcription factors.
    Barsyte-Lovejoy D; Galanis A; Sharrocks AD
    J Biol Chem; 2002 Mar; 277(12):9896-903. PubMed ID: 11786537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors.
    Whitmarsh AJ; Yang SH; Su MS; Sharrocks AD; Davis RJ
    Mol Cell Biol; 1997 May; 17(5):2360-71. PubMed ID: 9111305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
    Wu Z; Woodring PJ; Bhakta KS; Tamura K; Wen F; Feramisco JR; Karin M; Wang JY; Puri PL
    Mol Cell Biol; 2000 Jun; 20(11):3951-64. PubMed ID: 10805738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotonicity activates transcription through ERK-dependent and -independent pathways in renal cells.
    Zhang Z; Yang XY; Cohen DM
    Am J Physiol; 1998 Oct; 275(4):C1104-12. PubMed ID: 9755064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups.
    Strahl T; Gille H; Shaw PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11563-8. PubMed ID: 8876175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.
    Janknecht R; Hunter T
    EMBO J; 1997 Apr; 16(7):1620-7. PubMed ID: 9130707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
    Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.
    Ducret C; Maira SM; Lutz Y; Wasylyk B
    Oncogene; 2000 Oct; 19(44):5063-72. PubMed ID: 11042694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
    Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
    Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
    Ferrer I; Blanco R; Carmona M
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):48-58. PubMed ID: 11597764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.